0000000000425877

AUTHOR

Cigna V

showing 6 related works from this author

Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus

2006

researchProduct

The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer.

2007

researchProduct

Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management

2008

angiodysplasia
researchProduct

Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients

2006

researchProduct

Peri-operative bridgning therapy with low molecular weight heparin in patients requiring interruption of long-term oral anticoagulant therapy

2006

researchProduct

La profilassi chirurgica di pazienti con carenza congenita di FVII

2005

researchProduct